[Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D003316:Corneal Diseases / Q000209:etiology / Q000517:prevention & control; D003921:Diabetes Mellitus, Experimental / Q000473:pathology*; D004728:Endothelium, Corneal / Q000187:drug effects / Q000473:pathology; D010793:Phthalazines / Q000494:pharmacology / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D010793:Phthalazines; D011724:Pyridazines; C042829:ponalrestat; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase